Cargando…
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
Disulfiram (DS), an anti-alcoholism drug, shows very strong cytotoxicity in many cancer types. However its clinical application in cancer treatment is limited by the very short half-life in the bloodstream. In this study, we developed a poly lactic-co-glycolic acid (PLGA)-encapsulated DS protecting...
Autores principales: | Wang, Zhipeng, Tan, Jiao, McConville, Christopher, Kannappan, Vinodh, Tawari, Patricia Erebi, Brown, James, Ding, Jin, Armesilla, Angel L., Irache, Juan M., Mei, Qi-Bing, Tan, Yuhuan, Liu, Ying, Jiang, Wenguo, Bian, Xiu-Wu, Wang, Weiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364371/ https://www.ncbi.nlm.nih.gov/pubmed/27521693 http://dx.doi.org/10.1016/j.nano.2016.08.001 |
Ejemplares similares
-
The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells
por: Tawari, Patricia Erebi, et al.
Publicado: (2015) -
Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
por: Liu, Peng, et al.
Publicado: (2014) -
Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line
por: Butcher, Kate, et al.
Publicado: (2018) -
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021) -
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
por: Najlah, Mohammad, et al.
Publicado: (2019)